CPHL announcements Citi Pharma Ltd.
Citi Pharma Ltd. (CPHL) has 100 notices stored from the exchange, from 10 Dec 2024 to 02 Nov 2026. The newest is dated 02 Nov 2026; the titles below are the exchange’s own words.
Every notice stored, newest first
| Date | Kind | Title as filed | |
|---|---|---|---|
| 02 Nov 2026 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 30 September 2026 | |
| 02 Nov 2026 | Financial results | Financial Results for the Quarter Ended 30 September 2026 | |
| 30 Oct 2026 | Board meeting | Board Meeting In Progress | — |
| 30 Oct 2026 | Material information | Material Information | |
| 28 Oct 2026 | General meeting | Certified true copy of the resolutions passed in the Annual General Meeting of the Company | |
| 26 Oct 2026 | Management change | Change of Chief Financial Officer | |
| 23 Oct 2026 | Board meeting | Board Meeting | |
| 19 Oct 2026 | Material information | Material Information | |
| 07 Oct 2026 | Report sent to shareholders | Transmission of Annual Report for the Year Ended 30 June 2026 | |
| 07 Oct 2026 | General meeting | Notice of Annual General Meeting - Post Publication | |
| 06 Oct 2026 | General meeting | Notice of Annual General Meeting (Prior to Publication) | |
| 05 Oct 2026 | Financial results | Financial Results for the Year Ended 30 June 2026 | |
| 28 Sep 2026 | Board meeting | Board Meeting | |
| 18 Sep 2026 | General meeting | Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 18 September 2026 | |
| 28 Aug 2026 | General meeting | Notice of Extraordinary General Meeting | |
| 10 Aug 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 07 Aug 2026 | Announcement | Chief Financial Officer | |
| 09 Jul 2026 | General meeting | Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 08 July 2026 | |
| 09 Jul 2026 | General meeting | Minutes of Extraordinary General Meeting REVOKED | |
| 08 Jul 2026 | Material information | Material Information | |
| 01 Jul 2026 | Board meeting | Board Meeting Other Than Financial Results | |
| 15 Jun 2026 | General meeting | Notice of Extraordinary General Meeting | |
| 21 May 2026 | Material information | Material Information | |
| 06 May 2026 | Material information | Material Information | |
| 30 Apr 2026 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 31st March 2026 | |
| 30 Apr 2026 | Financial results | Financial Results for the Quarter Ended 31 March 2026 | |
| 27 Apr 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 23 Apr 2026 | Board meeting | Board Meeting | — |
| 23 Apr 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 22 Apr 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 30 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 17 Mar 2026 | Management change | Appointment of Company Secretary | — |
| 17 Mar 2026 | Management change | Appointment of Chief Financial Officer | — |
| 13 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 03 Mar 2026 | Material information | Material Information | |
| 27 Feb 2026 | Corporate briefing | Presentation - Corporate Briefing Session | |
| 27 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Feb 2026 | Material information | Material Information | |
| 26 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 25 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 20 Feb 2026 | Corporate briefing | Corporate Briefing Session | |
| 18 Feb 2026 | Report sent to shareholders | Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 | |
| 13 Feb 2026 | Financial results | Financial Results for the Quarter Ended December 31, 2025 | |
| 11 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 04 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 03 Feb 2026 | Board meeting | Board meeting | — |
| 03 Feb 2026 | Board meeting | Board Meeting REVOKED | — |
| 30 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 30 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 30 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 30 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 23 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 22 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 21 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 20 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 13 Nov 2025 | General meeting | Certified True Copy of the Resolutions Passed in the Annual General Meeting | |
| 06 Nov 2025 | Dividend or bonus payment | Credit of Final Cash Dividend (2025) | |
| 30 Oct 2025 | Report sent to shareholders | TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED | |
| 29 Oct 2025 | Financial results | Financial Results for the Quarter Ended | |
| 29 Oct 2025 | Board meeting | Board Meeting Other Than Financial Results (Post Election BOD Meeting) | — |
| 24 Oct 2025 | Board meeting | Board Meeting | — |
| 20 Oct 2025 | General meeting | Notice of Election of Directors u/s 159(4) of the Companies Act, 2017 | |
| 16 Oct 2025 | Material information | CLARIFICATION REGARDING NEWS CIRCULATING ON SOCIAL MEDIA PLATFORMS | |
| 07 Oct 2025 | Report sent to shareholders | Transmission of Annual Report for the Year Ended | |
| 06 Oct 2025 | General meeting | Notice of Annual General Meeting | |
| 02 Oct 2025 | Financial results | Financial Results for the year ended | |
| 25 Sep 2025 | Board meeting | Board Meeting | — |
| 12 Sep 2025 | Material information | Material Information | |
| 06 Aug 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | — |
| 26 Jun 2025 | General meeting | Certified Copy of the Resolutions adopted in the Extra Ordinary General Meeting of Citi Pharma Limited , held on Thursday 26 June 2025 | |
| 13 Jun 2025 | General meeting | Notice of Extra ordinary general meeting | |
| 13 Jun 2025 | General meeting | Notice of extraordinary general meeting REVOKED | |
| 12 Jun 2025 | Announcement | Director | — |
| 21 May 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 19 May 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | |
| 02 May 2025 | Report sent to shareholders | Transmission of financial statements for the Nine Months period ended 31 March 2025 | |
| 30 Apr 2025 | Financial results | Financial Results for the Quarter ended | |
| 23 Apr 2025 | Board meeting | Board Meeting | — |
| 16 Apr 2025 | General meeting | EXTRACT OF RESOLUTION PASSED VIA CIRCULATION | |
| 16 Apr 2025 | Material information | Material Information | |
| 27 Mar 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Mar 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 04 Mar 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | |
| 03 Mar 2025 | Report sent to shareholders | Transmission of Quarterly Financial Statements for the Half Year Ended 31 December 2024 | |
| 28 Feb 2025 | Financial results | Financial Results for the Quarter ended December 31, 2024 | |
| 27 Feb 2025 | Material information | Material Information | |
| 21 Feb 2025 | Board meeting | Board Meeting | — |
| 12 Feb 2025 | Regulatory notice | Half Yearly Progress Report for utilization of the proceeds for the half year ended December 31, 2023 | |
| 11 Feb 2025 | Regulatory notice | Half Yearly Progress Report for utilization of the proceeds for the half year ended December 30, 2023 REVOKED | |
| 11 Feb 2025 | Regulatory notice | Annual Progress Report for the year ended June 30, 2024 | |
| 07 Feb 2025 | Announcement | Post meeting Briefing | |
| 07 Feb 2025 | Board meeting | Decision of the Board Meeting Held on 2025-02-06 | |
| 06 Feb 2025 | Board meeting | Board Meeting in Progress | — |
| 30 Jan 2025 | Board meeting | Board Meeting Other Than Financial Results | |
| 23 Jan 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 16 Dec 2024 | Material information | Material Information | |
| 10 Dec 2024 | Material information | Material Information |
Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
By kind
- Shareholding disclosure: 29
- Board meeting: 15
- General meeting: 15
- Material information: 13
- Financial results: 8
- Report sent to shareholders: 8
- Announcement: 3
- Management change: 3
- Regulatory notice: 3
- Corporate briefing: 2
- Dividend or bonus payment: 1
Counted from the 100 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
More on CPHL
- CPHL share price and overview
- CPHL dividend history
- Pharmaceuticals sector
- CWHC announcements · Crestwell Healthcare Limited
- FEROZ announcements · Ferozsons Laboratories Limited
- GLAXO announcements · GlaxoSmithKline Pakistan Limited
- ABOT announcements · Abbott Laboratories (Pakistan) Limited
- HALEON announcements · Haleon Pakistan Limited
- HINOON announcements · Highnoon Laboratories Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .